Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imitavir phosphate + sofosbuvir in genotype 1 chronic hepatitis C
CTR20180228Phase 3Completed
- Sponsor
- Guangdong Dongyangguang Pharmaceutical
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of yimitasvir, sofosbuvir in hepatitis C virus infection, sponsored by Guangdong Dongyangguang Pharmaceutical. Started Mar 2018; status: completed.
02
Drugs
yimitasvirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20180228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180228.